生物标志物 生物标志物
Katherine Gong1,2, Jigyasha Timsina1,2, Muhammad Ali1,2
1Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
概括
这项研究确定了78种与阿尔茨海默病 (AD) 相关的血蛋白,并验证了血pTau217作为生物标志物. 核酸链接免疫三明治测试 (NULISA) 平台在诊断神经退行性疾病方面显示出前景.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 生物标志物发现发现
背景情况:
- 血分析为神经退行性疾病提供最少侵入性的生物标志物.
- 核酸链接免疫三明治测试 (NULISA) 平台被用于量化123个血蛋白.
- 这项研究包括3000多名患有阿尔茨海默氏症 (AD),勒维体痴呆症 (DLB),前性痴呆症 (FTD),帕金森病 (PD) 和对照患者.
研究的目的:
- 为了确定神经退行症的一般和疾病特异性血蛋白生物标志物.
- 评估NULISA平台在量化这些生物标志物的表现.
- 为了将血蛋白水平与已确定的神经成像和液体生物标志物相关联.
主要方法:
- 使用NULISA对3668个样本中的123个血蛋白质进行量化.
- 对AD,DLB,FTD和PD进行了差异丰度,ROC和AUC分析.
- 分析包括与粉样蛋白PET,蛋白PET,CSF Aβ42 / Aβ40和CDR得分的相关性.
主要成果:
- 78种与AD相关的蛋白质,2种与DLB相关的蛋白质,2种与FTD相关的蛋白质,1种与PD相关的蛋白质.
- 血pTau217的准确性很高 (AD的AUC为0.81,粉样蛋白阳性为0.95).
- 血pTau217和百叶状体水平之间达到了很高的一致性 (93.59%).
结论:
- 在神经退行性疾病中,NULISA是量化血蛋白质的可靠平台.
- 血pTau217是一种经过验证的AD预测生物标志物,与神经成像标志物有很强的相关性.
- 这些发现支持NULISA在神经退行性疾病诊断中的研究和临床应用的潜力.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516